4.6 Review

The Endocannabinoid System and Cannabidiol: Past, Present, and Prospective for Cardiovascular Diseases

Journal

PHARMACEUTICALS
Volume 14, Issue 9, Pages -

Publisher

MDPI
DOI: 10.3390/ph14090936

Keywords

endocannabinoid system; endocannabinoids; cannabinoid receptors; phyto-cannabinoids; synthetic cannabinoids; cardiomyopathy

Funding

  1. European Research Area Network on Cardiovascular Diseases [JTC2018-046 DENIM]
  2. Fondazione Istituto Europeo di Oncologia e del Centro Cardiologico Monzino
  3. Fondazione Umberto Veronesi [FUV-17/16/15GOWRAN]
  4. Ministero della salute della Repubblica italiana [RC 2019/21 MPP 5A]

Ask authors/readers for more resources

The endocannabinoid system is a complex and diverse regulatory network, with alterations and dysfunctions observed in almost every category of disease. Shifting attitudes toward cannabis not only bring new therapeutic prospects, but also raise other issues.
In the past, cannabis was commonly associated with mysticism and illegality. Fortunately, in recent years perspectives and discourses have changed. More prominence has been given to the rigorous scientific effort that led to the discovery of cannabis' many physiological actions and endogenous signalling mechanisms. The endocannabinoid system is a complex and heterogeneous pro-homeostatic network comprising different receptors with several endogenous ligands, numerous metabolic enzymes and regulatory proteins. Therefore, it is not surprising that alterations and dysfunctions of the endocannabinoid system are observed in almost every category of disease. Such high degree of pathophysiological involvement suggests the endocannabinoid system is a promising therapeutic target and prompted the translation of resurgent scientific findings into clinical therapies. Shifting attitudes toward cannabis also raised other matters such as increased patient awareness, prescription requests, self-medication, recreational use, recognition of new knowledge gaps, renewed scientific activity, and seemingly exponential growth of the cannabis industry. This review, following a general overview of cannabis and the endocannabinoid system, assiduously describes its role within the context of cardiovascular diseases, paying particular attention to the Janus influence that endocannabinoid system modulators can have on the cardiovascular system.

Authors

I am an author on this paper
Click your name to claim this paper and add it to your profile.

Reviews

Primary Rating

4.6
Not enough ratings

Secondary Ratings

Novelty
-
Significance
-
Scientific rigor
-
Rate this paper

Recommended

No Data Available
No Data Available